publication venue for
- Single-dose high-dose-rate brachytherapy versus two and three fractions for locally advanced prostate cancer.. -. 2024
- Platelet glycoprotein Ibα provides radiation protection.. 143-148. 2021
- Dosimetry of local failure with single dose 19 Gy high-dose-rate brachytherapy for prostate cancer.. 93-98. 2021
- Multi-institutional analysis of stereotactic body radiation therapy for operable early-stage non-small cell lung carcinoma.. 44-49. 2019
- Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis.. 188-196. 2018
- Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer.. 121:294-298. 2016
- [(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.. 118:72-8. 2015
- Dosimetric predictors of biochemical control of prostate cancer in patients randomised to external beam radiotherapy with a boost of high dose rate brachytherapy.. 110:110-3. 2013